Ibrutinib‐associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non‐Hodgkin lymphoma: An observational study

Rosa Ruchlemer(Shaare Zedek Medical Center), Tamar Lachish(Shaare Zedek Medical Center), Koh Okamoto(Rush University Medical Center), Yair Herishanu(Tel Aviv University), Jennifer R. Brown(Dana-Farber Cancer Institute), Talha Munir(Leeds Teaching Hospitals NHS Trust), Naama Bogot(Shaare Zedek Medical Center), Marcel Nijland, Rogier Mous(University Medical Center Utrecht), Tamar Tadmor(Bnai Zion Medical Center), Carole Soussain(Hôpital René Huguenin), Benjamin J. Arthurs(VA Portland Health Care System), Ronen Ben‐Ami(Tel Aviv University), Maya Korem(Hadassah Medical Center), Regev Cohen(Laniado Hospital), Ohad Benjamini(Sheba Medical Center), Julia A. Messina(Duke University), Maskit Bar‐Meir(Shaare Zedek Medical Center), Noélie Barzic(Hôpital Lyon Sud), Arnon P. Kater(Sanford Burnham Prebys Medical Discovery Institute), Marion Malphettes(Hôpital Saint-Louis), Preetesh Jain(The University of Texas MD Anderson Cancer Center), Fransien de Boer(Ikazia Ziekenhuis), Stephen P. Mulligan(Royal North Shore Hospital), Barbara Eichhorst, Jacob M. Rowe(City Of Hope National Medical Center), Brian T. Hill(Cleveland Clinic), Bat‐Sheva Gottesman(Meir Medical Center), Sanne H. Tonino(Amsterdam UMC Location University of Amsterdam)
Mycoses
September 14, 2019
Cited by 80


Related Papers